PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Synthesis, Characterization and Crystal Structure Studies of 1-(4-Chloro-benzenesulfonyl)-piperidin-4-yl-diphenyl-methanol

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
1-(4-Chloro-benzenesulfonyl)-piperidin-4-yl-diphenyl-methanol was synthesized by the condensation of [piperidin-4-yl]-diphenyl-methanol with p-chlorobenzene sulfonylchloride in methylene dichloride as solvent and triethylamine as the base. The compound obtained was characterized by spectroscopic techniques and confirmed by X-ray crystallographic studies. The crystallographic data analysis reveals that the title compound crystallizes in the monoclinic space group P21/c with cell parameters a = 10.214(9capital A, ring, b = 11.371(5)cvapital A, ring, c = 20.939(16)capital A, ring, beta = 115.399(2), V = 2197(3) capital A, ring3 for Z = 4. The structure has been solved by direct methods and refined toR1 = 0.0560 for 3658 observed reflections with I > 2sigma(I). The piperidine ring is in a chair conformation. The geometry around the S atom is distorted from regular tetrahedron.
Rocznik
Strony
1191--1199
Opis fizyczny
Bibliogr. 19 poz., rys.
Twórcy
autor
autor
autor
  • Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore 570 006, India, rangappaks@gmail.com
Bibliografia
  • 1. Sugimoto H., Tsuchiya Y., Sugumi H., Highurashi K., Karibi N., limura Y, Sasaki A., Kawakami Y, Nakamura T. and Araki S., Med. Chem, 33, 1880 (1990).
  • 2. Mao C., Rakesh V., Venkatachalam T.K., Elise A.S. and Fatih M.U., Bioorg. Med. Chem. Lett., 8,2213 (1998).
  • 3. Henderson N.D., Plumb J.A., Robins D. J. and Workman P., Anticancer Drug Des., 11, 421 (1996).
  • 4. Kus C., Goker H., Avhan G., Ertan R., Altanlar N. and Akin A., Farmaco, 51, 413 (1996).
  • 5. Murata Y, Miyamoto E. and Ueda M., J. Pharm. Sci., 80, 26 (1991).
  • 6. Nagarajan K., Talwalker P.K., Shah R.K. and Shenoy S.J., Ind. J. Chem., 24B, 112 (1985).
  • 7. Ranise A., Schenone S., Bruno O., Bondavalli F., Filippelli W., Falcone G. and Rivaldi B., Il Farmaco, 56,647(2001).
  • 8. Li Wen-Guang, Zhang Xiao-Yu, Wu Yong-Jie, Gao Ming-Tang and Zheng Rong-Liang, J. Phar. and Pharmaco,558,941 (2006).
  • 9. Sathe D.G., Kulkami P.B. and Kulkami V.M., Ind. J. Chem., 32B, 475 (1993).
  • 10. GillesC.B., BattistaK., Peter J.C., Michael J.O., Liu J., Steven A.M and AllenB.R., Bioorg. Med. Chem. Lett., 16, 3524 (2006).
  • 11. Wang Y, Chackalamannil S., Hu Z., Clader J.W., Greenlee W, Billard W., Binch H., Crosby G., Dufry R.A., McQuade R., Lachowicz J.E. and Ruperto V., Bioorg. Med. Chem. Lett., 20, 2247 (2000).
  • 12. Otwinowski Z. and Minor W., Methods in Enzymology: Macromolecular Crystallography, Vol. 276, Carter C.W. Jr. and Sweet R.M.. Eds p. 307. Academic Press, New York, 1997.
  • 13. Mackay S., Gillmore C.J., Edwards C. and Shankland K., maXus: Computer Program for the Solution and Refirement of Crystal Structures, Bruker Nonius. The Netherlands, Mac Science, Japan University of Glasgow, 1999.                                                                            .
  • 14. Sheldrick G.M., SHELXS-97. Program for Crystal Structure Solution, Unversity of Göttingen,Germany, 1997.                                                                             .          .       .              .
  • 15. Sheldrick G.M., SHELXL-97. Program for Crystal Structure Solution, University of Göttingen, Germany, 1997.
  • 16. Johnson.K., ORTEPII: A FORTRAN Thermal Ellipsoid Program, Report ORNL-5138, OAK National Laboratory, Oak Ridge, Tennessee, USA, 1976.
  • 17. Cremer D. and Pople J.A., J. Am. Chem. Soc., 97, 1354 (1975).
  • 18. Cotton F.A. and Stokley P.F., J. Am. Chem. Soc., 92, 294 (1970).
  • 19. Bassindale A, The Third Dimension in Organic Chemistry, Ch. l, p. 11, John Wiley and Sons New York,1984.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUJ5-0014-0089
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.